Author

Hannah Fullalove

University of Exeter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Chia‐Ling KuoiD· 1 shared David R. MelzeriD· 1 shared Deniz TürkmeniD· 1 shared George A. KucheliD· 1 shared Jack BowdeniD· 1 shared Jane A. H. MasoliiD· 1 shared Janice L. AtkinsiD· 1 shared João DelgadoiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Chia‐Ling KuoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic variation in activating clopidogrel: longer-term outcomes in a large community cohort

Luke C. Pilling, Deniz Türkmen, Hannah Fullalove, Janice L. Atkins, João Delgado, Chia‐Ling Kuo, George A. Kuchel, Luigi Ferrucci, Jack Bowden, Jane A. H. Masoli, David R. Melzer

This study finds that CYP2C19 loss-of-function variants are associated with increased risk of ischemic stroke and MI in patients on long-term clopidogrel therapy in primary care.

BMJ Open · Dec 1, 2021Peer-reviewedGenetic & Genomic Medicine